GNI GroupGNIIF 84 Gross Margin % is 72.84% as of Mar. 2026, which is 14% below its 10-year median of 84.42. GuruFocus rates GNIIF with a GF Score™ of 84/100 and a GF Value™ of $17.11. The stock has 5 warning signs investors should review. Among 735 Biotechnology companies, GNI Group ranks better than 63.4% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. GNI Group's Gross Profit for the
three
months ended in Mar. 2026 was $25.4 Mil. GNI Group's Revenue for the
three
months ended in Mar. 2026 was $34.8 Mil. Therefore, GNI Group's Gross Margin % for the quarter that ended in Mar. 2026 was 72.84%.
Warning Sign:
GNI Group Ltd gross margin has been in long-term decline. The average rate of decline per year is -2.8%.
The historical rank and industry rank for GNI Group's Gross Margin % or its related term are showing as below:
GNIIF'
s Gross Margin % Range Over the Past 10 Years
Min: 73.58 Med: 84.42 Max: 87.39
Current: 73.58
During the past 13 years, the highestGross Margin % of GNI Group was 87.39%. The lowest was 73.58%. And the median was 84.42%.
GNIIF's Gross Margin % is ranked better than 63.4% of 735
companies
in the Biotechnology industry
Industry Median: 60.9
vs GNIIF: 73.58
GNI Group had a gross margin of 72.84% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for GNI Group was -2.80% per year.
GNI Group (OTCPK:GNIIF) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
GNI Group had a gross margin of 72.84% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
GNI Group Gross Margin % Related Terms
GNI Group Gross Margin % Historical Data
* Premium members only.
The historical data trend for GNI Group's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GNIIF vs VRTX, REGN, ALNY: Gross Margin % Comparison
For the Biotechnology subindustry, GNI Group's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GNI Group Gross Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, GNI Group's Gross Margin % distribution charts can be found below:
* The bar in red indicates where GNI Group's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
GNI Group (GNIIF) has a Gross Margin % of 72.84% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on GNI Group and its competitors. This is 14% below median its historical median of 84.42. Over the past decade, GNI Group's Gross Margin % has ranged from 73.58 to 87.39. According to the industry distribution chart, GNI Group ranks #269 out of 735 companies in the Biotechnology industry, placing it in the top 36.6%.
Is GNI Group's Gross Margin % too high?
GNI Group's current Gross Margin % of 72.84% is 14% below median its 10-year median of 84.42. Over the past 10 years, this metric has ranged from a low of 73.58 to a high of 87.39. The Biotechnology industry median Gross Margin % is 60.90. GNI Group's value of 72.84% is 19.6% above this industry median. Based on the distribution chart, GNI Group ranks #269 out of 735 companies in the Biotechnology industry, which is above the industry midpoint. Overall, GNI Group has a GF Score™ of 84/100, reflecting its overall financial health beyond just this single metric.
How does GNI Group's Gross Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, GNI Group ranks #269 out of 735 companies for Gross Margin %. This puts GNI Group in the upper half of its industry. The industry median Gross Margin % is 60.90. GNI Group's value of 72.84% is 19.6% above this benchmark. Historically, GNI Group's own Gross Margin % has ranged from 73.58 to 87.39 over the past decade. While the company's 10-year median is 84.42 vs. the industry median of 60.90, GNI Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Biotechnology company?
The median Gross Margin % among Biotechnology companies is 60.90, based on 735 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GNI Group's current Gross Margin % of 72.84% is 19.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on GNI Group and its competitors. For the Biotechnology industry, the median Gross Margin % is 60.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GNI Group's current Gross Margin % is 72.84%, which is 14% below median its own 10-year median of 84.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GNI Group stock overvalued right now?
GNI Group (GNIIF) has a current Gross Margin % of 72.84%. The stock's GF Value™ is $17.11, compared to a current price of $15.50 — trading 9.4% below its estimated fair value. The current Gross Margin % is 72.84%, which is 14% below median its 10-year median of 84.42 and 19.6% above the Biotechnology industry median of 60.90. GNI Group's overall GF Score™ is 84/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For GNI Group (GNIIF), the current Gross Margin % is 72.84% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GNI Group (GNIIF) Overvalued in 2026?
Based on GuruFocus' analysis, GNI Group stock appears to be undervalued.
The current stock price of $15.50 is trading 9.4% below its estimated GF Value™ of $17.11.
Key valuation signals for GNIIF:
Gross Margin %: 72.84% (14% below median its 10-year median of 84.42)
GF Value™: $17.11 vs. price of $15.50 (9.4% below fair value)
Industry Position: 19.6% above the Biotechnology median (#269 of 735)
No single metric tells the full story. See the GNIIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GNI Group Ltd is a clinical stage drug development company. It works on the treatment of diseases that are more common in Asia, especially Japan and China. It is engaged in the discovery, development, manufacture, and sale of drugs for the treatment of cancer and inflammatory diseases.
84GF Score
Get the complete analysis for GNIIF
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GNIIF has been successfully added to your 
